Related references
Note: Only part of the references are listed.Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Abatacept and Sodium Thiosulfate for Treatment of Recalcitrant Juvenile Dermatomyositis Complicated by Ulceration and Calcinosis
Bita Arabshahi et al.
JOURNAL OF PEDIATRICS (2012)
A Randomized, Pilot Trial of Etanercept in Dermatomyositis The Muscle Study Group
Anthony A. Amato et al.
ANNALS OF NEUROLOGY (2011)
Double Trouble Therapeutic Challenges in Patients With Both Juvenile Dermatomyositis and Psoriasis
Nikki N. Kim et al.
ARCHIVES OF DERMATOLOGY (2011)
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M. Dastmalchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis
P. Riley et al.
RHEUMATOLOGY (2008)
Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients
P. Efthimiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence
RK Bode et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: Preliminary observations
GJD Hengstman et al.
EUROPEAN NEUROLOGY (2003)
Expression of TNFα by muscle fibers in biopsies from children with untreated juvenile dermatomyositis:: Association with the TNFα-308A allele
TO Fedczyna et al.
CLINICAL IMMUNOLOGY (2001)
IFN-α suppresses activation of nuclear transcription factors NF-κB and activator protein 1 and potentiates TNF-induced apoptosis
SK Manna et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
